Congenital Talipes Equino Varus (CTEV) is most commonly treated with the Ponseti method. Despite the efficacy of this method, recurrence rates of up to 48% have been documented in literature in children aged four and under. We performed a retrospective review of children diagnosed with CTEV in Rotorua region from the years 2013 - 2018 to determine the rates of recurrence and factors contributing to this. Out of the 44 children that were diagnosed with CTEV, 13 were lost to follow-up. The remaining 31 children who were categorized into a recurrence (n=14) and non-recurrence (n=17) groups giving a recurrence rate of 45.2%. 67.7% of children diagnosed with CTEV in Rotorua were Māori with an OR = 1.07 when comparison Māori and non-Māori children who recurred. Gestation at birth in the recurrence group was higher 39.6 weeks compared to 38.4 weeks in the non-recurrence group (p = 0.012). Children in the recurrence group were at increased odds (OR = 1.21) of having perinatal issues in comparison to the non-recurrence group. The Pirani score was higher in the recurrence group (6) in comparison to the non-recurrence group (5.05) (p = 0.023). Amongst the children who recurred the mean age of the first documented recurred was 848.9 days with a mean number of 2.07 recurrences per child. 50% of children in the recurrence group went on to have a tibialis tendon transfer and 35.7% of children went on to have an Achilles tendon lengthening after a one or more Achilles tenotomies. In all children in the recurrence group there were issues with compliance to the Denis Browne Boots and Bar system. Risk of recurrence in CTEV is multifactorial and further investigation into ways to manage compliance from a clinician point of view is required.